> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Tissue Agnostic Therapies
- URL: https://www.fdaweb.com/workshop-on-tissue-agnostic-therapies/
- Published: 2018-02-27T12:00:00.000Z
- Updated: 2026-09-14T23:25:49.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140854

*Federal Register* notice: FDA has announced a 5/9 public workshop on “Tissue Agnostic Therapies in Oncology: Regulatory Considerations for Orphan Drug Designation.” The workshop is intended to discuss factors the agency should consider when evaluating drugs for orphan designation that treat a tissue-agnosticdisease or condition in oncology, and additional factors related to orphan exclusivity it should consider when approving a product with such an indication. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-02-27/pdf/2018-03961.pdf?ref=fdaweb.com).